NSE · NATCOPHARM
Natco Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#453
of 5,004 stocks
🏆 New peak
▲ 181W
Peak #453 · 01 Oct 2026
A midcap name in Healthcare, Natco Pharma Limited trades at an undemanding earnings multiple, is seeing revenue slip, and earns a healthy return on equity.
Market Cap
14,812.25 Cr
P/E Ratio
10.45
P/B Ratio
1.61
ROE
15.38%
ROCE
16.26%
Dividend Yield
0.54%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 735.20 Cr | 739.10 Cr | 647.30 Cr | 1,363.00 Cr |
| Net Profit | 206.50 Cr | 269.00 Cr | 151.30 Cr | 517.90 Cr |
| EPS | 11.53 | 14.96 | 8.46 | 28.94 |
| Operating Profit | 198.60 Cr | 155.00 Cr | 170.60 Cr | 626.80 Cr |
Shareholding pattern
Promoter
49.42%
Public
50.58%
PUBLIC BREAKDOWN
FII
16.99%
DII
5.62%
MF (within DII)
1.92%
Individuals
25.11%
Mutual fund holdings
₹260.24
Cr total
68
Schemes
20
Fund Houses
₹260.24 Cr
Total Exposure
Tata Mutual Fund₹108.04 Cr (41.5%)
Sundaram Mutual Fund₹49.78 Cr (19.1%)
Aditya Birla Sun Life Mutual Fund₹13.46 Cr (5.2%)
Nippon India Mutual Fund₹13.35 Cr (5.1%)
HDFC Mutual Fund₹12.50 Cr (4.8%)
Others₹63.11 Cr (24.2%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 01 Oct 2026 | Rights | Rights 2:21 @ Premium Rs 748/- |
| 20 Aug 2026 | Dividend | Interim Dividend - Rs 1.50 Per Share |
| 18 Feb 2026 | Dividend | Interim Dividend - Rs 1.50 Per Share |
| 20 Nov 2025 | Dividend | Interim Dividend - Rs 1.50 Per Share |
| 19 Aug 2025 | Dividend | Interim Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.